Corcept Therapeutics Announces Second Quarter 2015 Results and Provides Corporate Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
Corcept Therapeutics (CORT) Tops Q2 EPS by 2c
August 5, 2015 5:17 PM EDTCorcept Therapeutics (NASDAQ: CORT) reported Q2 EPS of ($0.02), $0.02 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $12 million versus the consensus estimate of $11.67 million.
For earnings history and earnings-related data on Corcept Therapeutics (CORT) click here.
... More